Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.52 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.41 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.31 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29210205 | 0.94 | EP300 (0.46) | EP300GRIK1GRIK2FFAR3HDAC3 | |
| SCHEMBL243912 | 0.86 | EP300 (0.41) | EP300GRIK1GRIK2FFAR3 | |
| SCHEMBL1977291 | 0.86 | EP300 (0.41) | EP300GRIK1GRIK2FFAR3ALDH1A1 | |
| SCHEMBL27985112 | 0.84 | GRIK1 (0.41) | EP300GRIK1GRIK2FFAR3GABRR1 | |
| SCHEMBL28880870 | 0.84 | EP300 (0.40) | EP300GRIK1GRIK2FFAR3 | |
| SCHEMBL28881651 | 0.84 | EP300 (0.40) | EP300GRIK1GRIK2FFAR3 | |
| SCHEMBL1135184 | 0.84 | GRIK1 (0.41) | EP300GRIK1GRIK2FFAR3GABRR1 | |
| SCHEMBL28880872 | 0.84 | EP300 (0.40) | EP300GRIK1GRIK2FFAR3 | |
| SCHEMBL5328014 | 0.82 | GRIK1 (0.39) | EP300GRIK1GRIK2GABRR1 | |
| SCHEMBL2815797 | 0.82 | EP300 (0.39) | EP300GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 698 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705526-B1 | POLYMER TANNING AGENT | SNF GROUP (FR) | 2026-05-27 | — | — | EP | claimed |
| US-20260109952-A1 | MATERIAL AND METHOD FOR PRODUCING CELL RECEIVING SCAFFOLD | LUNG BIOTECHNOLOGY PBC (US) | 2026-04-23 | — | — | US | claimed |
| EP-4715941-A1 | COMPOSITE ELECTROLYTE MEMBRANE, MANUFACTURING METHOD THEREOF, AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG Energy Solution, Ltd. (KR) | 2026-03-25 | — | — | EP | claimed |
| EP-4045544-B1 | SUPER ADVANCED CONTROLLED RADICAL POLYMERIZATION | BASF COATINGS GMBH (DE) | 2026-03-18 | — | — | EP | claimed |
| EP-4685204-A1 | ADHESIVE MATERIAL, ADHESIVE TAPE, BONDED COMPOSITE, AND METHOD FOR ELECTRICALLY RELEASING A BONDED COMPOSITE | tesa SE (DE) | 2026-01-28 | — | — | EP | claimed |
| US-12534708-B2 | Material and method for producing cell receiving scaffold | LUNG BIOTECHNOLOGY PBC (US) | 2026-01-27 | — | — | US | claimed |
| EP-3829662-B1 | MATERIAL AND METHOD FOR PRODUCING CELL RECEIVING SCAFFOLD | LUNG BIOTECHNOLOGY PBC (US) | 2025-08-20 | — | — | EP | claimed |
| CN-118743774-A | Multifunctional medical pH indicating gauze with antibacterial and antioxidant functions and preparation method thereof | 武汉大学中南医院 | 2024-10-08 | — | — | CN | claimed |
| US-12029623-B2 | Dental materials using thermoset polymers | ALIGN TECHNOLOGY, INC. (US) | 2024-07-09 | — | — | US | claimed |
| EP-4087962-B1 | BIODEGRADABLE POLYMER FIBER FROM RENEWABLE RAW MATERIALS | TREVIRA GMBH (DE) | 2024-03-13 | — | — | EP | claimed |
| EP-0625527-B1 | Process for making pressure sensitive adhesive | ADCO PRODUCTS INC (US) | 2000-03-08 | — | — | EP | claimed |
| EP-0713498-B1 | POLAR PRESSURE-SENSITIVE ADHESIVES | AVERY DENNISON CORP (US) | 1999-09-29 | — | — | EP | claimed |
| US-5919894-A | Process for preparing polymers with recurring succinyl units | BAYER AG (DE) | 1999-07-06 | — | — | US | claimed |
| EP-0823923-B1 | PROCESS FOR PREPARING POLYMERS WITH RECURRING SUCCINYL UNITS | BAYER AG (DE) | 1999-01-27 | — | — | EP | claimed |
| EP-0871501-A1 | STERILIZATION INDICATORS AND METHODS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-10-21 | — | — | EP | claimed |
| US-5698270-A | Process for the preparation of antiscratch and antiabrasion shaped articles based on acrylic polymers | ATOHAAS HOLDING C.V. | 1997-12-16 | — | — | US | claimed |
| WO-1996040299-A1 | STERILIZATION INDICATORS AND METHODS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-12-19 | — | — | WO | claimed |
| EP-0685511-A2 | Process for the preparation of antiscratch and antiabrasion shaped articles based on acrylic polymers | ATOHAAS HOLDING C.V. (NL) | 1995-12-06 | — | — | EP | claimed |
| EP-0215978-B1 | LIQUID ELECTROPHORETIC DEVELOPER COMPOSITION | AGFA-GEVAERT N.V. (BE) | 1990-03-21 | — | — | EP | claimed |
| EP-0324536-A1 | Improved leather | EXXON CHEMICAL PATENTS INC. (US) | 1989-07-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534708-B2 | Material and method for producing cell receiving scaffold | COL2A1, COL1A1, COL14A1 | EP300 3464/4885GRIK1 4258/4885GRIK2 3917/4885 |
| US-20260109952-A1 | MATERIAL AND METHOD FOR PRODUCING CELL RECEIVING SCAFFOLD | COL2A1, COL1A1, COL14A1 | EP300 3889/4885GRIK1 4486/4885GRIK2 4483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.